Fernando
Lecanda Cordero
Profesional Investigador
National Cancer Institute
Rockville, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von National Cancer Institute (9)
2024
-
Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma
Cancer Epidemiology, Vol. 92
2020
-
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients with Osteosarcoma
JAMA Oncology, Vol. 6, Núm. 5, pp. 724-734
2018
-
Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients
International Journal of Cancer, Vol. 142, Núm. 8, pp. 1594-1601
2015
-
A genome-wide scan identifies variants in NFIB associated with metastasis in patients with osteosarcoma
Cancer Discovery, Vol. 5, Núm. 9, pp. 920-931
-
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Journal of the National Cancer Institute, Vol. 107, Núm. 12
-
Germline TP53 Variants and Susceptibility to Osteosarcoma
Journal of the National Cancer Institute, Vol. 107, Núm. 7
2014
-
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633
2013
-
Genome-wide association study identifies two susceptibility loci for osteosarcoma
Nature Genetics, Vol. 45, Núm. 7, pp. 799-803
2004
-
Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis
Laboratory Investigation, Vol. 84, Núm. 8, pp. 999-1012